Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

Author:

Lerner Seth P.1,Bajorin Dean F.23,Dinney Colin P.4,Efstathiou Jason A.5,Groshen Susan6,Hahn Noah M.7,Hansel Donna8,Kwiatkowski David9,O’Donnell Michael10,Rosenberg Jonathan23,Svatek Robert11,Abrams Jeffrey S.12,Al-Ahmadie Hikmat2,Apolo Andrea B.13,Bellmunt Joaquim14,Callahan Margaret23,Cha Eugene K.2,Drake Charles7,Jarow Jonathan15,Kamat Ashish4,Kim William16,Knowles Margaret17,Mann Bhupinder12,Marchionni Luigi7,McConkey David4,McShane Lisa18,Ramirez Nilsa19,Sharabi Andrew67,Sharpe Arlene H.14,Solit David23,Tangen Catherine M.20,Amiri Abdul Tawab1,Van Allen Eliezer14,West Pamela J.21,Witjes J. A.22,Quale Diane Zipursky23

Affiliation:

1. Baylor College of Medicine, Houston, TX, USA

2. Memorial Sloan Kettering Cancer Center, New York, NY, USA

3. Weill Medical College of Cornell University, New York, NY, USA

4. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

5. Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

6. USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

7. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

8. University of California, La Jolla, San Diego, CA, USA

9. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

10. The University of Iowa, IA, USA

11. UT Health Science Center San Antonio, San Antonio, TX, USA

12. Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

13. Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

14. Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA

15. Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD, USA

16. University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

17. Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK

18. Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA

19. The Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA

20. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

21. The Emmes Corporation, Rockville, MD, USA

22. Department of Urology, Radboud UMC, Nijmegen, The Netherlands

23. Bladder Cancer Advocacy Network, Bethesda, MD, USA

Publisher

IOS Press

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3